Employment Verification for Aimmune Therapeutics.

About Aimmune Therapeutics

Aimmune Therapeutics is an American biopharmaceutical company focused on the development and commercialization of treatments for life-threatening food allergies. The company was founded in 2011 and is headquartered in Brisbane, California. Aimmune’s lead product is called Palforzia, which was approved by the US Food and Drug Administration (FDA) in early 2020 for the treatment of peanut allergy in children and adolescents ages 4 through 17. Palforzia is a standardized oral immunotherapy product that is meant to increase tolerance to peanut protein. Aimmune is also developing a similar treatment for egg allergy. The company’s research and development efforts are focused on developing therapies based on immunotherapy, or the process of retraining the immune system to tolerate allergens. Beyond its work on food allergies, Aimmune is also exploring the application of its immunotherapy platform to other types of allergies. Aimmune has partnerships with several major pharmaceutical companies, including Nestle Health Science and Regeneron, and has received substantial funding from both private investors and government organizations. As of 2020, the company has a market capitalization of around $2 billion.

The information on this page is not an endorsement of Truv’s services by Aimmune Therapeutics and is meant to be purely informational.

Verify Aimmune Therapeutics Employees

Truv provides quick, secure and cost-effective employment and income verifications for thousands of verifiers. The process is simple and automated and most employees are verified in under 24 hours. You only pay for successful verification and can save on average 50% compared to competitors. Thousands of verifiers love Truv because it’s been never been easier and more streamlined to verify an employee, learn more.